Document is current
Any future updates will be listed below
-
Authors
Miyazaki, Yusuke
Kambe, Daiji
Imadera, Yumiko
Yamasaki, Hironori
Uchimura, Naohisa
Uchiyama, Makoto
-
Funding
Funding for this research was provided by:
Taisho Pharmaceutical Co., Ltd.
- License Information
-
More Information
Article History
Received: 28 November 2025
Accepted: 16 May 2026
First Online: 23 May 2026
Declarations
:
: This study was approved by the Hakata Clinic Institutional Review Board (approval no. 1546P1CP-10) on May 11, 2023.
: All participants were provided with sufficient information to make a decision to get involved in the study and written informed consent was obtained from them before enrollment.
: YM, DK, YI, and HY are employees of Taisho Pharmaceutical Co. Ltd. NU received grants from Eisai Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Merck Sharp & Dohme; and Takeda Pharmaceutical Co., Ltd. MU provided consulting services and received personal fees from Alfresa Pharma Co.; Nxera Pharma Japan Co., Ltd.; Lixil Co.; Sanofi S.A.; and Taisho Pharmaceutical Co., Ltd.
